Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Wuxi Acryl Technology Co., Ltd. (603722.SS)
Wuxi, CN
Wuxi Acryl Technology Co., Ltd., a Chinese enterprise established in 1999 and headquartered in Wuxi, specializes in manufacturing and distributing a diverse portfolio of resins and chemical products. The company's offerings encompass polyester, acrylic, polyurethane, high-performance epoxy, and various specialized resins. They also supply specific chemical compounds including isobornyl acrylates, methacrylates, cycloaliphatic acrylates, and polyether amines. Furthermore, Wuxi Acryl provides polymers tailored for applications in optical devices, advanced composite materials, and other particular resin-based solutions.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.76% | -12.13% | -10.64% | -11.66% | -11.15% | -11.53% | -6.38% | -33.37% | -16.86% | +115.69% | +115.69% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-10 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.3% Q1'26: +40.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-72.7% Q1'26: -160.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-23.7% Q1'26: -9.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-9.7% Q1'26: -9.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-6.5% Q1'26: -7.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+3.7% Q1'26: +1.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-14.17× Q1'26: -2.53× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
504.99M
est: 523.80M (-3.6%)
|
538.05M
est: 681.00M (-21.0%)
|
880.23M
est: 680.00M (+29.4%)
|
713.09M
est: 713.00M (+0.0%)
|
536.76M
est: 540.00M (-0.6%)
|
466.25M
est: 413.36M (+12.8%)
|
486.40M
est: 458.00M (+6.2%)
|
760.00M
760.00M – 760.00M
+65.9% YoY
|
1.16B
1.16B – 1.16B
+52.0% YoY
|
1.50B
1.50B – 1.50B
+29.8% YoY
|
| EBITDA |
71.73M
est: 74.34M (-3.5%)
|
88.09M
est: 96.65M (-8.9%)
|
144.47M
est: 96.51M (+49.7%)
|
170.34M
est: 101.20M (+68.3%)
|
54.29M
est: 76.64M (-29.2%)
|
12.50M
est: 41.69M (-70.0%)
|
-12.98M
est: 46.19M (-128.1%)
|
76.65M
76.65M – 76.65M
+65.9% YoY
|
116.48M
116.48M – 116.48M
+52.0% YoY
|
151.18M
151.18M – 151.18M
+29.8% YoY
|
| EBIT |
44.26M
est: 44.97M (-1.6%)
|
59.81M
est: 58.47M (+2.3%)
|
113.13M
est: 58.38M (+93.8%)
|
139.09M
est: 61.21M (+127.2%)
|
25.68M
est: 46.36M (-44.6%)
|
-24.52M
est: 18.34M (-233.7%)
|
-47.15M
est: 20.32M (-332.0%)
|
33.73M
33.73M – 33.73M
+65.9% YoY
|
51.25M
51.25M – 51.25M
+52.0% YoY
|
66.52M
66.52M – 66.52M
+29.8% YoY
|
| Net Income |
39.21M
est: 44.66M (-12.2%)
|
51.78M
est: 66.99M (-22.7%)
|
100.44M
est: 84.86M (+18.4%)
|
120.17M
est: 124.16M (-3.2%)
|
23.92M
est: 24.12M (-0.8%)
|
-19.65M
est: 1.85M (-1,160.6%)
|
-35.20M
est: 1.85M (-2,000.0%)
|
45.39M
45.39M – 45.39M
+2,350.0% YoY
|
166.75M
166.75M – 166.75M
+267.3% YoY
|
282.55M
282.55M – 282.55M
+69.4% YoY
|
| SGA |
37.87M
est: 22.41M (+69.0%)
|
45.58M
est: 29.14M (+56.4%)
|
49.84M
est: 29.09M (+71.3%)
|
52.63M
est: 30.51M (+72.5%)
|
42.94M
est: 23.10M (+85.9%)
|
42.07M
est: 28.33M (+48.5%)
|
20.47M
est: 31.39M (-34.8%)
|
52.10M
52.10M – 52.10M
+65.9% YoY
|
79.17M
79.17M – 79.17M
+52.0% YoY
|
102.75M
102.75M – 102.75M
+29.8% YoY
|
| EPS |
0.45
est: 0.50 (-10.0%)
|
0.59
est: 0.75 (-21.3%)
|
1.15
est: 0.95 (+21.1%)
|
1.37
est: 1.39 (-1.4%)
|
0.27
est: 0.27 (+0.0%)
|
-0.22
est: 0.02 (-1,200.0%)
|
-0.38
est: 0.02 (-2,000.0%)
|
0.49
0.49 – 0.49
+2,350.0% YoY
|
1.80
1.80 – 1.80
+267.3% YoY
|
3.05
3.05 – 3.05
+69.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jian Wang | Deputy General Manager | — | male |
| Jun Chang | Board Secretary | — | male |
| Li Feng | Financial Manager & Accounting Supervisor | — | female |
| Weimin You | Deputy GM & Director | — | male |
| Wenquan Zhang | Deputy GM & Director | — | male |
| Xiaoli Cui | Deputy GM & Director | — | female |
| Xuejun Zhu | Chairman & GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603722.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
